427
Participants
Start Date
December 18, 2017
Primary Completion Date
March 31, 2021
Study Completion Date
June 30, 2021
Limerick University Hospital, Limerick
University Hospital Waterford, Waterford
Royal Cornwall Hospital, Truro
Royal Devon & Exeter Hospital, Exeter
Derriford Hospital, Plymouth
Broomfield Hospital Chelmsford, Chelmsford
Queen's Hospital, Romford
Aberdeen Royal Infirmary, Aberdeen
Queen Alexandra Hospital, Portsmouth
Medway Maritime Hospital, Gillingham
Blackpool Victoria Hospital, Blackpool
Royal Oldham Hospital, Manchester
Queens Medical Centre, Nottingham
Ipswich Hospital, Ipswich
Heart of England NHS Foundation Trust, Birmingham
Russells Hall Hospital, Dudley
St Bartholomew's Hospital, London
Bradford Royal Infirmary, Bradford
St James's University Hospital, Leeds
Monklands Hospital, Airdrie
Bristol Haematology and Oncology Centre, Bristol
Addenbrooke's Hospital, Cambridge
University Hospital Wales, Cardiff
Croydon University Hospital, Croydon Health Services NHS Trust, Croydon
Western General Hospital, Edinburgh
Beatson West of Scotland Cancer Centre, Glasgow
Guy's Hospital, London
King's College Hospital, London
The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust, Middlesbrough
Oxford University Hospitals NHS Foundation Trust, Oxford
Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT, Sheffield
Royal Stoke University Hospital, Cancer Centre, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent
Singleton Hospital, Swansea
Lead Sponsor
Incyte Biosciences UK
INDUSTRY